One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals Post author: Post published:November 16, 2023 Post category:uncategorized The frequency of viral rebound (VR) among acute coronavirus disease 2019 patients. You Might Also Like Active feedback improves pharmacist participation in heart failure treatment November 18, 2024 New compound V-161 offers hope in the fight against antibiotic-resistant bacteria January 23, 2025 New method predicts sepsis and organ failure in children March 25, 2024